Condition: Atopic Dermatitis (AD) · Sponsor: Daniel Kaplan
The purpose of this study is to understand cellular and molecular interactions in the skin of participants with mild-to-moderate AD, and how botulinum toxin alters these interactions.
This description comes directly from the study's public registry record.
Charity Ruhl, LPN · 4126472013 · ruhlcl@upmc.edu
Anna Davis, MD · 4126475633 · davisa60@upmc.edu
Always discuss trial participation with your own doctor first.
| University of Pittsburgh Medical Center | Pittsburgh, Pennsylvania, United States | Not Yet Recruiting |
| UPMC Department of Dermatology | Pittsburgh, Pennsylvania, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06928246